Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News |  Global Antibody Drug Conjugates Market US$ 4.6 Billion by 2021The global antibody drug conjugates market expected to reach US$ 4.6 billion by 2021, growing at CAGR 30.2% over the forecast period, owing to increasing drug prices and rapid approval of new treatments.
https://www.ihealthcareanalyst.com/ The global antibody drug conjugates market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global antibody drug conjugates market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global antibody drug conjugates market report provides the detailed market landscape (market drivers, restraints, opportunities) The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments. Major players operating in the global antibody drug conjugates market and profiled in this report include AbbVie, Agensys, Inc., Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ImmunoGen, Inc., Immunomedics, Inc., NBE-Therapeutics, Novartis AG, Pfizer, Sanofi, Seattle Genetics, Inc., and Takeda Pharmaceutical Company Limited. 1. Marketed Drugs 1.1. Adcetris or SGN-35 (Brentuximab vedotin) 1.2. Kadcyla or T-DM1 (Trastuzumab emtansine) 2. Pipeline Drugs 2.1. Rova-T or SC16LD6.5 (Rovalpituzumab tesirine) 2.2. CDX‑011 (Glembatumumab vedotin) 2.3. Besponsa or CMC-544 (Inotuzumab ozogamicin) 2.4. IMGN853 (Mirvetuximab soravtansine) 2.5. SGN‑CD33A (Vadastuximab talirine) 3. Geography 3.1. North America (U.S., Canada) 3.2. Latin America (Brazil, Mexico, Rest of LA) 3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU) 3.4. Asia Pacific (Japan, China, India, Rest of APAC 3.5. Rest of the World 4. Company Profiles 4.1. AbbVie 4.2. Agensys, Inc. 4.3. Bayer AG 4.4. Concortis Biotherapeutics 4.5. F. Hoffman-La Roche Ltd. 4.6. ImmunoGen, Inc. 4.7. Immunomedics, Inc. 4.8. NBE-Therapeutics 4.9. Novartis AG 4.10.Pfizer 4.11.Sanofi 4.12.Seattle Genetics, Inc. 4.13.Takeda Pharmaceutical Company Limited To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client's specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com End
|
| |||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number